At AAOS 2016, Bioventus is introducing the CellXtract™ novel cell and bone marrow extraction tool and SIGNAFUSE™, a bioactive bone graft putty recently acquired from BioStructures.
Source: Bioventus LLC
Other products on display include:
- Recently-launched SUPARTZ-FX five-injection HA
- OsteoAMP® Allogeneic Morphogenetic Protein, acquired from Advanced Biologics
- As well as other Bioventus products, DUROLANE® HA and the EXOGEN® Ultrasound Bone Healing System
At AAOS 2016, Bioventus is introducing the CellXtract™ novel cell and bone marrow extraction tool and SIGNAFUSE™, a bioactive bone graft putty recently acquired from BioStructures.
Source: Bioventus LLC
Other products on display include:
Recently-launched SUPARTZ-FX five-injection HA
OsteoAMP® Allogeneic...
At AAOS 2016, Bioventus is introducing the CellXtract™ novel cell and bone marrow extraction tool and SIGNAFUSE™, a bioactive bone graft putty recently acquired from BioStructures.
Source: Bioventus LLC
Other products on display include:
- Recently-launched SUPARTZ-FX five-injection HA
- OsteoAMP® Allogeneic Morphogenetic Protein, acquired from Advanced Biologics
- As well as other Bioventus products, DUROLANE® HA and the EXOGEN® Ultrasound Bone Healing System
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.